Enrichment of virtual hits by progressive shape-matching and docking.
暂无分享,去创建一个
Jiwon Choi | Ningning He | Sukjoon Yoon | Nayoung Kim | Nayoung Kim | Sukjoon Yoon | Jiwon Choi | Ningning He
[1] Nanda Ghoshal,et al. Combinatorial Library Enumeration and Lead Hopping using Comparative Interaction Fingerprint Analysis and Classical 2D QSAR Methods for Seeking Novel GABAA α3 Modulators , 2009, J. Chem. Inf. Model..
[2] Robert J. Jilek,et al. "Lead hopping". Validation of topomer similarity as a superior predictor of similar biological activities. , 2004, Journal of medicinal chemistry.
[3] Andrew Smellie,et al. Surrogate docking: structure-based virtual screening at high throughput speed , 2005, J. Comput. Aided Mol. Des..
[4] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[5] Gisbert Schneider,et al. Scaffold-hopping potential of fragment-based de novo design: the chances and limits of variation. , 2009, Combinatorial chemistry & high throughput screening.
[6] Jürgen Bajorath,et al. Virtual screening methods that complement HTS. , 2004, Combinatorial chemistry & high throughput screening.
[7] Ruben Abagyan,et al. Optimization of High Throughput Virtual Screening by Combining Shape‐Matching and Docking Methods. , 2008 .
[8] Philip Prathipati,et al. Global Bayesian Models for the Prioritization of Antitubercular Agents , 2008, J. Chem. Inf. Model..
[9] Wei Li,et al. Identifying Novel Molecular Structures for Advanced Melanoma by Ligand-Based Virtual Screening , 2009, J. Chem. Inf. Model..
[10] Pierre Tufféry,et al. Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity , 2009, BMC Bioinformatics.
[11] David A. Cosgrove,et al. Lead Hopping Using SVM and 3D Pharmacophore Fingerprints. , 2005 .
[12] G. Klebe. Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.
[13] Bing Xiong,et al. ScafBank: a public comprehensive Scaffold database to support molecular hopping , 2009, Acta Pharmacologica Sinica.
[14] Pedro Alexandrino Fernandes,et al. Protein–ligand docking: Current status and future challenges , 2006, Proteins.
[15] R. Mannhold,et al. Multivariate analysis of experimental and computational descriptors of molecular lipophilicity , 1998, Journal of computer-aided molecular design.
[16] Ajay N. Jain,et al. Scoring functions for protein-ligand docking. , 2006, Current protein & peptide science.
[17] J A McCammon,et al. Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.
[18] F. Petitet,et al. Assessing the chemical diversity of an hsp90 database. , 2010, European journal of medicinal chemistry.
[19] William J. Welsh,et al. Identification of a Minimal Subset of Receptor Conformations for Improved Multiple Conformation Docking and Two-Step Scoring , 2004, J. Chem. Inf. Model..
[20] T. Tuccinardi. Docking-based virtual screening: recent developments. , 2009, Combinatorial chemistry & high throughput screening.
[21] Ismael Zamora,et al. SHOP: A Method For Structure‐Based Fragment and Scaffold Hopping , 2009, ChemMedChem.
[22] Yvonne C. Martin,et al. Application of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping , 2008, J. Chem. Inf. Model..